149 related articles for article (PubMed ID: 32474289)
1. The 2015 IPND Criteria Increases the Yield in Diagnosis of Neuromyelitis Optica Spectrum Disorder in Thai Patients Compared to the 2006 Diagnostic Criteria.
Rattanathamsakul N; Kaveeta C; Siritho S; Thakolwiboon S; Prayoonwiwat N
Mult Scler Relat Disord; 2020 Aug; 43():102218. PubMed ID: 32474289
[TBL] [Abstract][Full Text] [Related]
2. Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients.
He M; Wu L; Huang D; Yu S
Mult Scler Relat Disord; 2020 Nov; 46():102459. PubMed ID: 32853894
[TBL] [Abstract][Full Text] [Related]
3. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria.
Papeix C; Beigneux Y; Maillart E; de Seze J; Lubetzki C; Vukusic S; Collongues N; Marignier R
Eur J Neurol; 2020 Nov; 27(11):2250-2256. PubMed ID: 32559008
[TBL] [Abstract][Full Text] [Related]
5. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.
Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R
Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Hyun JW; Jeong IH; Joung A; Kim SH; Kim HJ
Neurology; 2016 May; 86(19):1772-9. PubMed ID: 27164713
[TBL] [Abstract][Full Text] [Related]
7. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.
Rajput HM; Hassan M; Badshah M
Mult Scler Relat Disord; 2023 Jun; 74():104656. PubMed ID: 37068371
[TBL] [Abstract][Full Text] [Related]
8. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Wingerchuk DM; Banwell B; Bennett JL; Cabre P; Carroll W; Chitnis T; de Seze J; Fujihara K; Greenberg B; Jacob A; Jarius S; Lana-Peixoto M; Levy M; Simon JH; Tenembaum S; Traboulsee AL; Waters P; Wellik KE; Weinshenker BG;
Neurology; 2015 Jul; 85(2):177-89. PubMed ID: 26092914
[TBL] [Abstract][Full Text] [Related]
9. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
[TBL] [Abstract][Full Text] [Related]
10. The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study.
Li X; Xu H; Zheng Z; Ouyang H; Chen G; Lou Z; Chen H; Zhang J; Zhan Y; Mao H; Zhang C; Zhao M; Zhao Y
BMC Neurol; 2022 Aug; 22(1):304. PubMed ID: 35986246
[TBL] [Abstract][Full Text] [Related]
11. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates.
Hamid SH; Elsone L; Mutch K; Solomon T; Jacob A
Mult Scler; 2017 Feb; 23(2):228-233. PubMed ID: 27553618
[TBL] [Abstract][Full Text] [Related]
12. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
13. Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries.
Viktoria P; Trones KDP; Magyari M; Koch-Henriksen N; Iljicsov A; Rajda C; Nielsen HH; Lovas G; Rozsa C; Kristiansen BH; Stenager E; Frederiksen JL; Komoly S; Sellebjerg F; Petersen T; Illes Z
Mult Scler Relat Disord; 2021 Jun; 51():102879. PubMed ID: 33714126
[TBL] [Abstract][Full Text] [Related]
14. The relationship between aquaporin-4 antibody status and visual tract integrity in neuromyelitis optica spectrum disorders: A visual evoked potential study.
Barć K; Gospodarczyk-Szot K; Nojszewska M; Podlecka-Piętowska A; Zakrzewska-Pniewska B
Mult Scler Relat Disord; 2020 Sep; 44():102265. PubMed ID: 32575026
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia.
Sechi E; Puci M; Pateri MI; Zara P; Othmani S; Sotgiu S; Saddi MV; Leoni S; Fenu G; Melis M; Sotgiu G; Solla P; Cocco E; Frau J
Mult Scler Relat Disord; 2024 May; 85():105522. PubMed ID: 38461730
[TBL] [Abstract][Full Text] [Related]
16. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
18. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Jarius S; Aktas O; Ayzenberg I; Bellmann-Strobl J; Berthele A; Giglhuber K; Häußler V; Havla J; Hellwig K; Hümmert MW; Kleiter I; Klotz L; Krumbholz M; Kümpfel T; Paul F; Ringelstein M; Ruprecht K; Senel M; Stellmann JP; Bergh FT; Tumani H; Wildemann B; Trebst C;
J Neurol; 2023 Jul; 270(7):3341-3368. PubMed ID: 37022481
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and epidemiological aspects of neuromyelitis optic spectrum diseases in the russian population].
Simaniv TO; Kochergin IA; Zakharova MN; Korobko DS; Zaslavskii LG; Zelenova OV; Abramov SI
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):96-103. PubMed ID: 34460164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
